New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of ...
Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these ...
The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.
After treatment with bepirovirsen, however, 19% of patients achieved the strictly defined “functional cure” criteria. For the ...
The antisense oligonucleotide was even more effective in patients with relatively low viral activity. More than one-quarter of these individuals had undetectable levels of the virus in the blood for ...
Across two large trials, roughly 20% of people treated with bepirovirsen had undetectable levels of the virus after stopping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results